Abetimus
Abetimus
Abetimus (pronunciation: /əˈbɛtɪməs/) is a synthetic molecule that was developed for the treatment of Lupus nephritis.
Etymology
The term "Abetimus" is derived from the Latin word "Abet", meaning to aid or encourage, and the Greek word "Imus", meaning strong or powerful. This is in reference to the drug's intended function of aiding the body's immune system in combating the effects of Lupus nephritis.
Usage
Abetimus was designed to bind to double-stranded DNA antibodies, which are often present in individuals with SLE. By binding to these antibodies, Abetimus can help to reduce the severity of Lupus nephritis symptoms.
Related Terms
- Lupus nephritis: A serious complication of SLE, where the kidneys become inflamed.
- SLE: A chronic autoimmune disease that can affect any part of the body, most often affecting the skin, joints, kidneys, and nervous system.
- Antibodies: Proteins produced by the immune system to identify and neutralize foreign objects such as bacteria and viruses.
- DNA: Deoxyribonucleic acid, a molecule that carries most of the genetic instructions used in the development, functioning, and reproduction of all known living organisms and many viruses.
See Also
External links
- Medical encyclopedia article on Abetimus
- Wikipedia's article - Abetimus
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski